Atom Investors LP Cardiff Oncology, Inc. Transaction History

Atom Investors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.46 - $5.91 $3,974 - $16,087	-2,722 Reduced 15.11%	15,298 $81,000
Q4 2023 Feb 14, 2024	SELL	$0.96 - $1.55 $266 - $430	-278 Reduced 1.52%	18,020 $26,000
Q3 2022 Nov 08, 2022	SELL	$1.54 - $3.21 $23,870 - $49,755	-15,500 Reduced 45.86%	18,298 $28,000
Q1 2022 May 16, 2022	BUY	$2.11 - $7.25 $71,313 - $245,035	33,798 New	33,798 $84,000

12.3M

813K

91.1K

Ticker CRDF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,334,900
Market Cap $184M
Description
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.